FDA Orange Book · active-ingredient family
Eltrombopag choline
Eltrombopag choline is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:ALVAIZ · NDA 216774
1
Brand (NDA)
0
Generics (ANDA)
1
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ALVAIZRLD×4 | TEVA PHARMS INC | NDA 216774 | — | Nov 29, 2023 |
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 11072586 | Nov 05, 2038 | in 12 yr 7 mo | SubstanceProductU-3936 |
Eltrombopag choline — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
